A multicenter phase II study of pemetrexed as second-line chemotherapy for the treatment of hormone refractory prostate cancer (HRPC); Hoosier Oncology Group GU-0367

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16019-16019 ◽  
Author(s):  
N. M. Hahn ◽  
R. T. Zon ◽  
T. Jones ◽  
F. Ademuyiwa ◽  
W. M. Dugan ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Second Line ◽  
Oncology Group ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Hormone Refractory ◽  
Line Chemotherapy

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

2012 ◽  
Vol 69 (6) ◽  
pp. 1641-1645 ◽  
Author(s):  
Alberto Zaniboni ◽  
Enrico Aitini ◽  
Sandro Barni ◽  
Daris Ferrari ◽  
Stefano Cascinu ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Line Chemotherapy

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

scholarly journals Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients

Cancer ◽  
2007 ◽  
Vol 110 (3) ◽  
pp. 556-563 ◽  
Author(s):  
Jonathan E. Rosenberg ◽  
Vivian K. Weinberg ◽  
W. Kevin Kelly ◽  
Dror Michaelson ◽  
Maha H. Hussain ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Hormone Refractory Prostate Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Hormone Refractory ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document